Class III Flashcards
describe class III agents
AMIODARONE
- Multiple effects at K+, Ca2+, Na+ channels and Beta-receptors
–> Main effect: prolong phase 3 repolarization (INcrease QT
- useful for ventricular reentry/fibrillatory arrhythmia
- EFFECTIVE IN MANY TYPES OF ARRHYTHMIAS
describe MoA of AMIODARONE
- Blocks K+ channels = prolongs refractoriness and APD
- Blocks Na+ channels that are in the inactivated state
- block Ca+ channels –> slows SA node phase 4
- Slows conduction through the AV node
- Noncompetitive blockade of alpha, beta and M receptors
**EXPLAINS DIVERSE ANTIARRHYTHMIC ACTIONS
describe main clinical apps of amiodarone
- EFFECTIVE IN WIDE RANGE OF ARRHYTHMIAS, nOW VERY WIDELY USED
- conversion and slwoing of AF, maintaining sinus rhythm in AF
- AV nodal reentrant tachycardia
- tachycardias assocaited with the WPW syndrome
- PO for recurrent life-threatening VT or VF resistant to other Rx
- IV for ACute termination of VT or VF and is replacing LIDOCAIN as first-line therapy for out-of-hospital cardiac arrest
describe the pharmacology of amidoarone
- HIGHLY LIPID-SOLUBLE COMPOUND
- causes extremely variable and complex pharmacokinetics
- extensively metabolized to DEA
- DEA has antiarrhythmic potency > amiodarone
- rapidly concentrated in some tissues, including myocardium, but it accumulates mroe slowly in others –> Very large Vd
- UNTIL ALL TISSUES ARE SATURATED, RAPID REDISTIRBUTION OUT OF MYOCARDIUM MAY BE RESPONSIBLE FOR EARLY RECURRENCE OF ARRHYTHMIAS AFTER DISCONTINUATION OR RAPID DOSE REDUCTION
- after IV admin: T1/2 = 5-68 hours
- As tissues become saturated T1/2 = 13-103 days
describe adverse rx to amiodarone
- IV> 5mg/kg decreases cardiac contractility and PVR –> HYPOTENSION
–> usual dosages improve myocardial contracitlity
- MOST SERIOUS: LETHAL INTERSTITIAL PNEUMONITIS, (more frequent in patients with preexisting lung disease
- Hyperthyroidism or hypothyroidism (diverse effects)
- photosensitivity
- acumulation of corneal microdeposists
- elevated serum hepatic enzyme levels